Результаты поиска

Dietary Supplement Use among Older Cancer Survivors: Socio-Demographic Associations, Supplement Types, Reasons for Use, and Cost.

Most Americans take dietary supplements (DSs) and use is even higher among cancer survivors. This secondary analysis seeks to identify types, reasons, and costs of supplements used by 367 older cancer survivors enrolled in the Harvest for Health vegetable gardening trial and evaluate associations between supplement intake and medical/socio-demographic factors. Descriptive statistics were used to identify supplement type and reasons for use. Average market price was used to estimate cost. Fifty-nine percent of the sample reported supplement use. Female (OR 2.11, 95% CI 1.35-3.30), non-Hispanic

Совпадение в полном тексте источника
… The sample of older cancer survivors in this trial was distributed across Alabama. … Alabama Statewide Cancer Registry and Alabama Department of Vital Statistics. (data unpublished) Associated Data Supplementary Materials Click here for additional data file. …

Parent training interventions for parents with intellectual disability.

BACKGROUND: Research suggests that the number of intellectually disabled people with children is increasing. Intellectual disabilities do no … ation and the Ontario Ministry of Community and Social Services Research Grants Program; one by the Alabama Development Disabilities Council; one by the Best Practice Parenting Education Initiative of the Commonwealth Department of Family and Community Services and the New South Wales Aging and Disability Department; and one by ZonMw, The Netherlands Orga …

National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.

BACKGROUND: Over the past several decades, the overweight and obesity epidemic in the USA has resulted in a significant health and economic … hree adults (≥25 years) will have obesity. Although southern states, such as Oklahoma, Mississippi, Alabama, Arkansas, West Virginia, and Kentucky, are forecast to continue to have a high prevalence of obesity, the highest percentage changes from 2021 are projected in states such as Utah for adolescents and Colorado for adults. INTERPRETATION: Existing p …

Rural and Urban Differences in Vegetable and Fruit Consumption Among Older Cancer Survivors in the Deep South: An Exploratory Cross-Sectional Study.

BackgroundCancer survivors, especially those who are older, experience increased comorbidity and risk for secondary cancers. A varied dietar … l were obtained from October 2016 to November 2019 on 731 Medicare-eligible cancer survivors across Alabama.Main outcome measuresV&F consumption was measured by 2 items from the National Cancer Institute's dietary screener Eating at America's Table. Rural and urban residence was coded at the ZIP-code level using the US Department of Agriculture's Rural-Ur …

ASENT 2022 Annual Meeting.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… English, Department of Pediatrics, Division of Neurology at Children’s of Alabama and the University of Alabama at Birmingham;, Adrienne Samani, Department of Pediatrics, Division of Neurology at Children’s of Alabama and the University of Alabama at Birmingham; Andrea L. … Alexander, Department of Pediatrics, Division of Neurology at Children’s of Alabama and the University of Alabama at Birmingham; Department of Genetics, University of Alabama at Birmingham; UAB Civitan International Research Center (CIRC); UAB Center for Neurodegeneration and Experimental Therapeutics …

Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis.

Talquetamab is a GPRC5D × CD3 bispecific antibody approved for relapsed/refractory multiple myeloma (RRMM). This is the first real-world study to comprehensively report muco-cutaneous toxicities, infections, and efficacy of talquetamab in 151 patients across five countries with the longest follow-up reported enabling better efficacy and toxicity estimates. The median age was 64 years; high-risk cytogenetics were present in 42%; ECOG ≥ 2 in 22%; 12% had creatinine clearance < 30; and 55% would not have met MonumenTAL-1 eligibility. Patients received a median of 6 prior lines of therapy, 53% wer

Совпадение в полном тексте источника
… at Birmingham, Birmingham, Alabama, USA Rahul Banerjee, Fred Hutchinson Cancer Center, Seattle, Washington State, USA Dina Ben‐Yehuda, Hadassah University Hospital, Jerusalem, ISRAEL Jesús G. … at Birmingham, Birmingham, Alabama, USA Andrew Cowan, Fred Hutchinson Cancer Center, Seattle, Washington, USA Carlos Fernández de Larrea, Hospital Clínic de Barcelona, Barcelona, SPAIN Benjamin Derman, The University of Chicago Medicine, Chicago, Illinois, USA Juan Du, Changzheng Hospital; Naval Medical …